Avanos Medical Inc
NYSE:AVNS
EV/S
Enterprise Value to Sales
Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.
Market Cap | EV/S | ||||
---|---|---|---|---|---|
US |
Avanos Medical Inc
NYSE:AVNS
|
904.1m USD | 1.4 | ||
JP |
Hoya Corp
TSE:7741
|
6.3T JPY | 7.8 | ||
CH |
Alcon AG
SIX:ALC
|
36.3B CHF | 4.6 | ||
DK |
Coloplast A/S
CSE:COLO B
|
190B DKK | 8.2 | ||
US |
Align Technology Inc
NASDAQ:ALGN
|
20.4B USD | 5 | ||
US |
Cooper Companies Inc
NYSE:COO
|
18.8B USD | 5.9 | ||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
13.1T KRW | 303.9 | |
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
61.2B CNY | 14.2 | ||
UK |
ConvaTec Group PLC
LSE:CTEC
|
5.4B GBP | 58.9 | ||
US |
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.8B USD | 1.8 | ||
CA |
B
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.4B USD | 2.2 |
EV/S Forward Multiples
Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.